[BidClub_]

PERSON DIRECTORY

Salim Ismail

Salim Ismail appears in 105 indexed conversations across Moonshots. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.

105 EPISODES1 SHOW
3 episodes2 active
Language
MoonshotsEN · 143 min

Frontier Labs Want to Slow Down, OpenAI Delays Its 2026 IPO, Anthropic Flags 5 Bioweapon Cases

Peter DiamandisSalim IsmailDave BlundinDr. Alexander Wissner-Gross

Dario Amodei proposes slowing frontier releases through employee-level third-party evaluators, lab coordination, and international bioweapons cooperation, while Alex Wissner-Gross calls the campaign a possible “safety cartel.”Anthropic reports biological-weapons cases and says it can no longer confidently assure models remain below the dangerous threshold, strengthening the case for mutual API testing while leaving cartel-like coordination unresolved.

MoonshotsEN · 134 min

OpenClaw Debate: AI Personhood, Proof of AGI, and the ‘Rights’ Framework | EP #227

Peter DiamandisSalim IsmailDave BlundinDr. Alexander Wissner-Gross

OpenClaw’s breakthrough is autonomous, continuous agents that combine frontier or local open-weight models with memory, tools, and native messaging interfaces rather than a new foundation model.That distribution unlock also creates the gating risk: agents with access to email, payments, and open ports could cause industrial accidents, while compute-equity deals and falling intelligence costs accelerate infrastructure demand before personhood and control are resolved.

MoonshotsEN · 66 min

How the New Administration Will Impact Crypto, AI & Tech Globally w/ Ben Horowitz & Salim Ismail

Ben HorowitzPeter DiamandisSalim Ismail

Washington’s shift from “complete war with the industry” to “aggressive pro-tech” could release blocked exits and revive crypto development, but Stargate’s quoted $500 million and $500 billion figures remain unclear while energy constrains AI infrastructure.DeepSeek’s roughly 100-times-lower token cost and AI-driven drug design strengthen the case for decentralized innovation, yet founders still need operational discipline, physical trials, and supply chains that remain overwhelmingly Chinese.